Published in Int J Drug Policy on March 21, 2017
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet (2010) 12.82
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ (2009) 6.03
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS (2003) 5.53
Adverse effects of antiretroviral therapy. Lancet (2000) 4.84
Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med (2003) 3.81
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (2002) 3.45
Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis (2004) 3.20
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ (2003) 3.19
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting. PLoS One (2014) 2.20
Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend (2007) 2.15
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med (2003) 2.02
Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. J Acquir Immune Defic Syndr (2003) 1.58
The use of GEE for analyzing longitudinal binomial data: a primer using data from a tobacco intervention. Addict Behav (2006) 1.53
Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage (2005) 1.51
Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med (2005) 1.51
An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis (2013) 1.42
The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care (2009) 1.38
Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr (2004) 1.33
Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDS (2011) 1.33
Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis (2011) 1.29
Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr (2005) 1.21
Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDS (2004) 1.20
Impairment due to cannabis and ethanol: clinical signs and additive effects. Addiction (2010) 1.14
Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav (2013) 1.09
Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clin Infect Dis (2007) 1.08
Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting. AIDS Care (2011) 1.08
Marijuana and lung diseases. Curr Opin Pulm Med (2014) 1.05
Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use. J Int Assoc Physicians AIDS Care (Chic) (2005) 1.04
Cannabinoid administration attenuates the progression of simian immunodeficiency virus. AIDS Res Hum Retroviruses (2010) 1.00
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Clin Infect Dis (2014) 0.99
Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med (2012) 0.98
Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis (2015) 0.95
Marijuana as therapy for people living with HIV/AIDS: social and health aspects. AIDS Care (2007) 0.94
Predictors for non-adherence to antiretroviral therapy. Sex Health (2004) 0.89
Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco. AIDS Behav (2014) 0.89
Impact of unstable housing on all-cause mortality among persons who inject drugs. BMC Public Health (2015) 0.85
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug Alcohol Rev (2015) 0.85
A safer alternative: Cannabis substitution as harm reduction. Drug Alcohol Rev (2015) 0.84
Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations. Front Microbiol (2015) 0.84
Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS (2001) 0.84
The combined effects of alcohol and cannabis on driving: Impact on crash risk. Forensic Sci Int (2014) 0.83
Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting. Drug Alcohol Depend (2013) 0.83
High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Rev (2014) 0.82
The causal effect of opioid substitution treatment on HAART medication refill adherence. AIDS (2015) 0.82
Is cannabis use associated with less opioid use among people who inject drugs? Drug Alcohol Depend (2015) 0.81
Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative. Clin Infect Dis (2015) 0.80
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status. AIDS Care (2015) 0.80
Marijuana use and viral suppression in persons receiving medical care for HIV-infection. Am J Drug Alcohol Abuse (2016) 0.78
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug Alcohol Rev (2016) 0.78
Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico. Nicotine Tob Res (2013) 0.78
Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting. AIDS (2015) 0.78
High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting. AIDS Behav (2015) 0.77
The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend (2015) 0.90
Associations between childhood trauma and non-fatal overdose among people who inject drugs. Addict Behav (2014) 0.76
Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. Addict Behav (2017) 0.75
Residential eviction and exposure to violence among people who inject drugs in Vancouver, Canada. Int J Drug Policy (2017) 0.75
Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis. Int J Drug Policy (2017) 0.75